Manulife (Manufacturers Life Insurance)
RXDX

Manulife (Manufacturers Life Insurance)’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RXDX Stock Details RXDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$4.49M Buy
2022
Q4 		$3.56M Buy
2022
Q3 		$950K Buy
2022
Q2 		$337K Sell
2022
Q1 		$455K Sell
2021
Q4 		$585 Buy